Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CORBF
Global Cord Blood
$0.55
-26.7%
$1.05
$0.25
$2.00
$66.85M-0.52113,893 shs200 shs
DocGo Inc. stock logo
DCGO
DocGo
$1.43
-1.4%
$1.50
$1.23
$5.68
$145.84M0.97755,240 shs500,647 shs
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
$3.50
-4.1%
$2.74
$0.13
$3.78
$312.32M0.021.23 million shs2.67 million shs
Exagen Inc. stock logo
XGN
Exagen
$7.00
-2.5%
$6.84
$1.78
$7.95
$149.10M1.58146,440 shs145,690 shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CORBF
Global Cord Blood
0.00%-26.67%-56.35%-15.38%-54.17%
DocGo Inc. stock logo
DCGO
DocGo
0.00%-4.03%-11.73%-32.55%-58.67%
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
0.00%+11.82%+47.06%+62.04%+550.56%
Exagen Inc. stock logo
XGN
Exagen
0.00%+0.14%-4.89%+55.90%+241.46%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CORBF
Global Cord Blood
N/AN/AN/AN/AN/AN/AN/AN/A
DocGo Inc. stock logo
DCGO
DocGo
1.501 of 5 stars
3.31.00.00.00.02.50.6
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
2.279 of 5 stars
3.82.00.00.03.10.80.0
Exagen Inc. stock logo
XGN
Exagen
2.682 of 5 stars
1.52.00.04.50.62.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CORBF
Global Cord Blood
0.00
N/AN/AN/A
DocGo Inc. stock logo
DCGO
DocGo
2.50
Moderate Buy$3.56148.95% Upside
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
3.50
Strong Buy$6.5085.71% Upside
Exagen Inc. stock logo
XGN
Exagen
3.00
Buy$7.507.14% Upside

Current Analyst Ratings Breakdown

Latest CORBF, TOI, DCGO, and XGN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/16/2025
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$6.00
7/15/2025
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/15/2025
Exagen Inc. stock logo
XGN
Exagen
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight
5/15/2025
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$7.00
5/15/2025
Exagen Inc. stock logo
XGN
Exagen
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$8.00 ➝ $7.00
5/13/2025
Exagen Inc. stock logo
XGN
Exagen
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$7.00 ➝ $8.00
5/12/2025
DocGo Inc. stock logo
DCGO
DocGo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$5.00 ➝ $1.45
5/9/2025
DocGo Inc. stock logo
DCGO
DocGo
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$4.00 ➝ $3.00
5/9/2025
DocGo Inc. stock logo
DCGO
DocGo
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
5/7/2025
Exagen Inc. stock logo
XGN
Exagen
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
(Data available from 7/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CORBF
Global Cord Blood
$196.12M0.34$0.39 per share1.40N/A
DocGo Inc. stock logo
DCGO
DocGo
$616.55M0.24$0.42 per share3.38$3.09 per share0.46
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
$393.41M0.79N/AN/A$0.05 per share70.00
Exagen Inc. stock logo
XGN
Exagen
$55.64M2.68N/AN/A$0.54 per share12.96
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CORBF
Global Cord Blood
$79.04MN/A0.00N/AN/AN/AN/AN/A
DocGo Inc. stock logo
DCGO
DocGo
$19.99M-$0.02N/A17.88N/A-0.12%2.52%1.70%8/6/2025 (Estimated)
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
-$64.66M-$0.70N/AN/A-15.38%-445.02%-34.13%8/12/2025 (Estimated)
Exagen Inc. stock logo
XGN
Exagen
-$15.11M-$0.84N/AN/AN/A-27.34%-133.69%-34.87%7/29/2025 (Estimated)

Latest CORBF, TOI, DCGO, and XGN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2025Q2 2025
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
-$0.13N/AN/AN/A$112.56 millionN/A
8/6/2025Q2 2025
DocGo Inc. stock logo
DCGO
DocGo
-$0.06N/AN/AN/A$77.58 millionN/A
7/29/2025Q2 2025
Exagen Inc. stock logo
XGN
Exagen
-$0.18N/AN/AN/A$16.25 millionN/A
5/14/2025Q1 2025
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
N/A-$0.18N/A-$0.21N/A$104.41 million
5/12/2025Q1 2025
Exagen Inc. stock logo
XGN
Exagen
-$0.20-$0.20N/A-$0.20$14.55 million$15.50 million
5/8/2025Q1 2025
DocGo Inc. stock logo
DCGO
DocGo
-$0.01-$0.09-$0.08-$0.09$104.25 million$96.03 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CORBF
Global Cord Blood
N/AN/AN/AN/AN/A
DocGo Inc. stock logo
DCGO
DocGo
N/AN/AN/AN/AN/A
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
N/AN/AN/AN/AN/A
Exagen Inc. stock logo
XGN
Exagen
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CORBF
Global Cord Blood
N/AN/AN/A
DocGo Inc. stock logo
DCGO
DocGo
N/A
2.44
2.44
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
14.58
1.79
1.59
Exagen Inc. stock logo
XGN
Exagen
2.87
2.32
2.32

Institutional Ownership

CompanyInstitutional Ownership
CORBF
Global Cord Blood
N/A
DocGo Inc. stock logo
DCGO
DocGo
56.44%
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
36.86%
Exagen Inc. stock logo
XGN
Exagen
75.25%

Insider Ownership

CompanyInsider Ownership
CORBF
Global Cord Blood
0.50%
DocGo Inc. stock logo
DCGO
DocGo
2.70%
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
8.50%
Exagen Inc. stock logo
XGN
Exagen
12.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
CORBF
Global Cord Blood
1,200121.55 millionN/ANot Optionable
DocGo Inc. stock logo
DCGO
DocGo
4,407101.98 million99.23 millionOptionable
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
66089.23 million81.65 millionNot Optionable
Exagen Inc. stock logo
XGN
Exagen
22021.30 million18.62 millionOptionable

Recent News About These Companies

Exagen Inc. Appoints Chas McKhann to Board of Directors
Exagen Insider Ups Holding During Year
Exagen Inc. Prices Public Offering of Common Stock
Exagen Inc. (XGN) Q1 2025 Earnings Call Transcript

New MarketBeat Followers Over Time

Media Sentiment Over Time

Global Cord Blood NYSE:CORBF

$0.55 -0.20 (-26.67%)
As of 07/18/2025 09:40 AM Eastern

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

DocGo stock logo

DocGo NASDAQ:DCGO

$1.43 -0.02 (-1.38%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$1.43 0.00 (0.00%)
As of 07/18/2025 07:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.

Oncology Institute stock logo

Oncology Institute NASDAQ:TOI

$3.50 -0.15 (-4.11%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$3.57 +0.07 (+2.00%)
As of 07/18/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Exagen stock logo

Exagen NASDAQ:XGN

$7.00 -0.18 (-2.51%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$7.02 +0.01 (+0.21%)
As of 07/18/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Exagen Inc. develops and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company offers AVISE Lupus that measures activation of the complement system by quantifying the level of B-cell C4d and erythrocyte bound C4d in the patient's blood; and AVISE APS, which consists of a panel of autoantibody tests that aids in the diagnosis and management of APS. In addition, it provides AVISE Vasculitis AAV, which utilizes a testing panel of individual analytes to provide physicians with results in the assessment and monitoring of anti-neutrophil cytoplasmic antibody associated vasculitis; AVISE SLE Prognostic, a panel of autoantibodies for assessing the potential for complications affecting the kidney, brain, and cardiovascular system; and AVISE Anti-CarP test, which identifies RA patients with severe disease. Further, the company offers AVISE SLE Monitor, a biomarker blood test; AVISE MTX, a patented and validated blood test; and AVISE HCQ, a blood test to monitor levels of hydroxychloroquine. It has a research collaboration and license agreement with Allegheny Health Network (AHN) Research Institute to develop novel patented biomarkers. The company was formerly known as Exagen Diagnostics, Inc. and changed its name to Exagen Inc. in January 2019. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California.